drugset / Trial / NCT01175824

Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies

NCT01175824

Phase 4 Completed 478 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

The study is a comparison of twice-daily insulin lispro low mixture versus once-daily basal insulin glargine and once-daily prandial insulin lispro, in participants with Type 2 Diabetes.

Timeline

Start
2011-04
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Lispro Protein / enzyme biologic Subcutaneous
Comparator insulin glargine Protein / enzyme biologic Subcutaneous